BiotechTube

IGC AD1 + Placebo

Phase 1Completed
1 views this week 0 watching💤 Quiet
Interest: 19/100
19
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Dementia of Alzheimer Type

Conditions

Dementia of Alzheimer Type

Trial Timeline

Jan 11, 2021 → Jun 20, 2021

NCT ID
NCT04749563

About IGC AD1 + Placebo

IGC AD1 + Placebo is a phase 1 stage product being developed by IGC Pharma for Dementia of Alzheimer Type. The current trial status is completed. This product is registered under clinical trial identifier NCT04749563. Target conditions include Dementia of Alzheimer Type.

What happened to similar drugs?

9 of 20 similar drugs in Dementia of Alzheimer Type were approved

Approved (9) Terminated (1) Active (10)
✅E2020 + PlaceboEisaiApproved
✅donepezil hydrochloride (Aricept)EisaiApproved
✅MecobalaminEisaiApproved
✅Donepezil hydrochloride + Donepezil matching placebo + Donepezil hydrochlorideEisaiApproved
✅Risperdal,reminylJohnson & JohnsonApproved
✅ENA713NovartisApproved
✅Rivastigmine Patch 9.5 cm2NovartisApproved

Hype Score Breakdown

Clinical
6
Activity
8
Company
5
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT04749563Phase 1Completed

Competing Products

20 competing products in Dementia of Alzheimer Type

See all competitors
ProductCompanyStageHype Score
[18F]NAV4694Navidea BiopharmaceuticalsPhase 3
26
AL001 + Placebo + Open label - AL001AlectorPhase 3
22
AL001AlectorPhase 2
25
ATH-1017 + PlaceboLeonaBioPhase 2
17
E2020 + PlaceboEisaiApproved
43
ARICEPTEisaiPhase 3
40
RasagilineEisaiPhase 2
35
Donepezil HydrochlorideEisaiPre-clinical
26
donepezil hclEisaiPhase 3
40
Donepezil 5 mg + Donepezil 10 mg + Donepezil matched placeboEisaiPhase 3
40
E2020 + E2020EisaiPhase 2
35
donepezil hydrochloride (Aricept)EisaiApproved
43
3 mg Donepezil hydrochloride + 5 mg Donepezil hydrochloride + 10 mg Donepezil hydrochloride + PlaceboEisaiPhase 2
35
E2020 + E2020EisaiPhase 3
40
Irsenontrine + PlaceboEisaiPhase 2
35
E2020EisaiPhase 2
35
MecobalaminEisaiApproved
43
E2020 + PlaceboEisaiPhase 3
40
Donepezil HydrochlorideEisaiPhase 3
40
Donepezil hydrochloride + Donepezil matching placebo + Donepezil hydrochlorideEisaiApproved
43